December 13, 2018
Therapy aims to reduce prostate cancer treatment side effects
Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.
By Craig Boerner